Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human papillomavirus (HPV) E7 antigen is a multifunctional oncoprotein encoded by high-risk HPV types. It plays a central role in the viral life cycle and is critical for the oncogenic transformation of host cells, contributing to the development of cancers such as cervical cancer. E7 disrupts cell cycle regulation by binding to and degrading tumor suppressor proteins like pRb, leading to uncontrolled cell proliferation. It is a diagnostic marker and therapeutic target in HPV-associated cancers and a key component in vaccine research.
Inhibition of tumor suppressor pathways, particularly pRb; recruitment of ubiquitin ligase complexes for protein degradation; activation of E2F-mediated transcription
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus E7 Antigen (None).